Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Form 8.3 - AXA INVESTMENT MANAGERS: Segro plc
-
Revolve Announces Acquisition of 30MWp Solar Development Project in Alberta
-
HiringBranch Joins AWS Partner Network Bringing Skills-Based Hiring AI to AWS Telecommunications, FinTech, and Contact Center Customers
-
3iQ and CoinDesk Indices Collaborate to Launch Funds Globally That Track the CoinDesk 20 Index
-
CVW CleanTech Announces Closing of $14 million Royalty Investment with Northstar Clean Technologies
-
General Copper Gold Reassesses Historical Drill Hole; Additional Samples Submitted for Assay
-
Zodiac Gold Announces Conversion of Reconnaissance License into Two New Exploration Licenses Covering 1,899 Square Kilometers in Liberia's Todi Shear Zone
-
Kalm Therapeutics Hires Former GSK Director Dr. Tomoko Maeda-Chubachi as Chief Medical Officer
-
Elektros and Next Realm AI to Revolutionize Energy Efficiency in Data Centers with Renewable Power Solutions
-
Phio Pharmaceuticals Announces Presentation at the 9th Annual CAR-TCR Summit in Boston, MA
-
Aethlon Medical Announces Activation of Royal Adelaide Hospital to Begin Patient Screening and Enrollment in Hemopurifier® Cancer Trial
-
GoveeLife Unveils the New Countertop Smart Ice Maker 1s
-
Celldex Announces Upcoming Late Breaking Oral Presentation of 52 Week Results from Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EADV Congress 2024
-
ERES REIT Declares September 2024 Monthly Distribution
-
Gibson Energy Announces Renewal of Normal Course Issuer Bid
-
Tree Island Steel Announces Quarterly Dividend
-
DO Apparel Expands Digital Production of Custom Jerseys for Large Sports Brands with Kornit Digital
-
Science 37 Earns Frost & Sullivan’s 2024 Global Company of the Year Award for Decentralized Clinical Trials
-
FSTEC Panel to Explore Hi Auto's Impact on Drive-Thru Efficiency and Workforce Experience
-
Elo Launches Groundbreaking Elo Pay M100 Mobile POS Tablet
-
Vera Therapeutics to Host In-Person R&D Day in New York to Discuss Potential Indication Expansion for Atacicept on October 2, 2024
-
ICAHN ENTERPRISES VINDICATED BY DISMISSAL OF MERITLESS LAWSUIT THAT PARROTED FALSE AND MISLEADING CLAIMS PUBLISHED BY HINDENBURG "RESEARCH"
-
Inotiv, Inc. Amends Its Credit Agreement and Secures Additional Liquidity
-
Kyverna Therapeutics Announces Leadership Update
-
Vuzix Receives $10 Million First Tranche Investment from Quanta Computer
-
BioAtla Presented Phase 2 Ozuriftamab Vedotin Clinical Trial Data Demonstrating Meaningful Antitumor Activity with Manageable Tolerability among Heavily Pretreated Patients with Squamous Cell Carcinom
-
Silvercorp Announces Filing of Updated Technical Report for the GC Mine
-
Lexicon Pharmaceuticals Announces Departure of President and Chief Operating Officer
-
InterDigital Announces Annual Recurring Revenue Target Of $1 Billion By 2030
-
Concord Medical Announces Obtaining Large Medical Equipment Procurement License for Its Proton Therapy Equipment
-
PRIVACY ALERT: East Valley Institute of Technology (EVIT) Under Investigation for Data Breach of 208,000 Students, Faculty, and Parents
-
Darmiyan, Inc. Announces Launch of Groundbreaking BrainSee Platform for Alzheimer's Testing
-
LG ELECTRONICS USA PARTNERS WITH NEW YORK YANKEES TO SUPPORT NYC FIELD RENOVATION
-
Wolters Kluwer revolutionizes professional audit with CCH Axcess™ Audit
-
Synchron Announces First Use of Amazon’s Alexa with a Brain Computer Interface
-
Lattice Semiconductor Appoints Ford Tamer as CEO
-
CrowdStrike Expands Cybersecurity Startup Accelerator with AWS and NVIDIA to Support the Next Generation of Global Cloud Security Companies
-
Bernhard Capital-Backed Grace Hebert Curtis Partners with Hastings+Chivetta
-
CAPREIT Announces September 2024 Distribution
-
CMCT Announces Actions to Accelerate Focus Towards Premier Multifamily Assets
-
Demand for Azure Printed Homes Surges as Company Exhibits, Presents and Receives Fast Company Innovation Acknowledgment
-
Harmonic Charts the Future of Broadband at SCTE TechExpo24
-
Ryan Specialty Completes Acquisition of Ethos Specialty Insurance’s P&C MGUs From Ascot Group Limited
-
Actuate Announces Upcoming Presentation on Initial Data on Elraglusib in Combination with FOLFIRINOX at the AACR Special Conference on Advances in Pancreatic Cancer Research
-
UroGen Receives New U.S. Patent Allowance for Next-Generation Mitomycin-Based Products Expected to Provide Protection Until December 2041
-
Mark Hudspeth Joins Pretium as Senior Managing Director to Lead Capital Markets
-
Moderne Ventures Closes over $230M for MV Fund III, Scaling its Modern Approach to Venture Investing
-
Study Published in the British Journal of Radiology Demonstrates IceCure's ProSense® is a Safe Procedure with 97.7% Technical Success Rate in Treating Tumors of the Lung, Bone, and Soft Tissues
-
Soluna Signs Term Sheet with Renewable Energy Leader for New Data Center Project
-
Presentation at the 2024 International HBV Meeting Highlights Antiviral Activity of EBT-107 as a Potential Anti-HBV Therapy
